Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantation

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Bone Marrow Transplantation

Topics

Physics

Optics

Medicine

Cancer Oncology

Immunology

Show all topics

DOI

10.1038/s41409-024-02328-w

License

CC-BY

Other Formats

PDF